Physicians’ awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a “Pituitary Society” survey

Overview of attention for article published in Pituitary, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#34 of 533)
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 49 X posts from 18 X users, with an upper bound of 49,088 followers.

https://t.co/kr5ExfoStO They purposefully held a meeting on the concerns of retention.

RT @GadoliniumToxic: Data from this questionnaire suggested that a knowledge deficit exists amongst #Pituitary neurosurgeons: "many are als…

RT @Wagner_Nephro: 🧠 From a survey at pituitary meetings, nearly half of the neurosurgeons were unaware of gadolinium-based contrast agent…

RT @Wagner_Nephro: 🧠“Lack of prior knowledge of new possible retention concerns regarding gadolinium in patients with normal renal function…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 45 additional X posts.